Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

clinical

- PMLiVE

Ketchum London’s CEO Denise Kaufmann heads for the US

The UK agency's deputpy CEO Jo-ann Robertson will move into Kaufmann's former role

ThromboGenics bolsters leadership team

Appoints Susan Schneider as CMO and Vinciane Vangeersdaele as CCO

Patient recruitment and engagement standards

Clinical trial awareness

- PMLiVE

Ann Barbier joins Translate Bio as its chief medical officer

She will take responsibility for leading the US biotech's clinical R&D

Orion appoints VP of oncology, R&D

Professor Heikki Joensuu joins from Helsinki University Hospital

- PMLiVE

Another well-deserved promotion at Porterhouse Medical

We are delighted to announce the promotion of one of our scientific staff, Emma, to the role of senior medical writer. Not only was Emma the winner of our 2016 Entrepreneur...

Porterhouse Medical Group

- PMLiVE

Zelluna appoints Miguel Forte as CEO

He joins the Norwegian biotech from Bone Therapeutics

- PMLiVE

Storm Therapeutics strengthens its board

Professor Paul Workman joins as an independent director

- PMLiVE

Good Relations appoints new executive director

Sophie Taylor-Roberts will head the agency’s health and wellbeing practice

IFPMA names new communications director

Helen Gallagher joins the association from Ferring Pharmaceuticals

Prime Global expands Core’s senior team

Norbert Brunhuber joins as director of client services

Magic of Lucid targets rare and specialist diseases

Lucid Group, the award-winning global medical communications company with offices in London, Buckinghamshire, Macclesfield and New York, has announced the launch of a new agency specialising in rare and specialist...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links